Extrahepatic manifestations of chronic viral hepatitis

被引:77
作者
Pyrsopoulos N.T. [1 ]
Reddy K.R. [1 ]
机构
[1] Division of Hepatology, Center for Liver Diseases, University of Miami School of Medicine, 1500 NW 12th Avenue, Suite 1100, Miami, 33136, FL
关键词
Chronic Viral Hepatitis; Interferon Alfa; Lichen Planus; Mixed Cryoglobulinemia; Polyarteritis Nodosa;
D O I
10.1007/s11894-001-0044-1
中图分类号
学科分类号
摘要
Hepatitis B (HBV) and C (HCV) viruses are well-recognized causes for chronic hepatitis, cirrhosis, and even for hepatocellular carcinoma. Apart from liver disease, these viral infections are known to be associated with a spectrum of extrahepatic manifestations. The prevalence of clinically significant extrahepatic manifestations is relatively low, but it can be associated with significant morbidity and even mortality. An awareness and recognition of these manifestations is of paramount importance in facilitating early diagnosis and in offering treatment. However, treatments are not necessarily effective, and patients may continue with disabling extrahepatic manifestations. Hepatitis B virus has been well recognized as causing a variety of manifestations that include skin rash, arthritis, arthralgia, glomerulonephritis, polyarteritis nodosa, and papular acrodermatitis. More recently, infection with hepatitis C virus has elicited considerable interest for its role in a spectrum of extrahepatic manifestations. Among the best-reported are cryoglobulinemia, glomerulonephritis, high titer of autoantibodies, idiopathic thrombocytopenic purpura, lichen planus, Mooren’s corneal ulcer, Sjögren’s syndrome, porphyria cutanea tarda, and necrotizing cutaneous vasculitis. The precise pathogenesis of these extrahepatic complications has not been determined, although the majority represent the clinical expression of autoimmune phenomena. © 2001, Current Science Inc.
引用
收藏
页码:71 / 78
页数:7
相关论文
共 53 条
[1]  
Laskus T., Radkowski M., Wang L.F., Et al., Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative strand viral RNA in various tissues, Hepatology, 28, pp. 1398-1404, (1998)
[2]  
Caputo R., Gelmetti C., Ermacora E., Et al., Gianotti-Crosti syndrome: a retrospective analysis of 308 cases, J Am Acad Dermatol, 26, pp. 207-210, (1992)
[3]  
Clark E., Kaplan B.I., Endocardial, arterial, and other mesenchymal alterations associated with serum sickness in man, Arch Pathol, 24, (1937)
[4]  
Trepo C.H., Thivolet J., Australia antigen,virus hepatitis and periarteritis nodosa, Presse Med, 78, (1970)
[5]  
Cacoub P., Lunel F.F., Du L.T.H., Polyarteritis nodosa and hepatitis C virus infection, Ann Intern Med, 16, pp. 605-606, (1992)
[6]  
Guillevin L., Lhote F., Gayraud M., Et al., Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome, Medicine, 75, pp. 17-28, (1996)
[7]  
Guillevin L., Lhote F., Cohen, Et al., Polyarteritis nodosa related to hepatitis B virus: a prospective study of 41 patients, Medicine, 74, pp. 238-253, (1995)
[8]  
Guillevin L., Lhote F., Sauvaget F., Et al., Treatment of polyarteritis nodosa related to hepatitis B virus with interferon alpha and plasma exchange, Ann Rheum Disease, 53, pp. 334-337, (1994)
[9]  
Lam K.C., Lai C.L., Trepo C.H., Et al., Deleterious effect of prednisolone in HbsAg-positive chronic active hepatitis, N Engl J Med, 304, pp. 380-386, (1981)
[10]  
Pinto P.C., Hu E., Bernestein-Singer M., Et al., Acute hepatic injury after withdrawal of immunosuppressive chemotherapy in patients with hepatitis B, Cancer, 65, pp. 878-884, (1990)